Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-25 @ 2:36 AM
NCT ID:
NCT02636634
Eligibility Criteria:
Inclusion Criteria:
* age between 18 and 75 years.
* Patient treated with radiosurgery for one or more brain metastases Free -Intervally between radiosurgical treatment and inclusion in the study at least four months.
* Lesion (S) treated (s) and followed (s) with the criteria for a clinically active lesion (progressive deficit, seizures, intracranial hypertension steroid-dependent) and / or MRI (increased volume of contrast enhancement with peri-lesional edema and mass effect on two successive examinations at 1 month interval).
* Karnofsky index\> 50.
* Prognostic compatible for survival with a follow-up at least three months from the date of inclusion.
* Effective contraception for women of childbearing potential or negative pregnancy test within 72 hours.
* Signed informed consent obtain
* Affiliation to the social security system
Exclusion Criteria:
* Contraindication to MRI examination
* Clearance of the creatinine incompatible with the injection of gadolinium
* No potential follow-up in middle or long term
* Pregnancy
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT02636634
Study Brief:
Protocol Section:
NCT02636634